Expert Opinion on Drug Safety

2.4k papers and 48.3k indexed citations i.

About

The 2.4k papers published in Expert Opinion on Drug Safety in the last decades have received a total of 48.3k indexed citations. Papers published in Expert Opinion on Drug Safety usually cover Oncology (340 papers), Surgery (326 papers) and Pharmacology (309 papers) specifically the topics of Pharmacovigilance and Adverse Drug Reactions (230 papers), Pharmaceutical studies and practices (147 papers) and Drug-Induced Adverse Reactions (119 papers). The most active scholars publishing in Expert Opinion on Drug Safety are Liberata Sportiello, Concetta Rafaniello, Icilio Cavero, Cristina Scavone and Annalisa Capuano.

In The Last Decade

Fields of papers published in Expert Opinion on Drug Safety

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Expert Opinion on Drug Safety. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Expert Opinion on Drug Safety

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Expert Opinion on Drug Safety. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Expert Opinion on Drug Safety with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025